...
首页> 外文期刊>Journal of Surgical Oncology >Lymphatic micrometastases in patients with early esophageal adenocarcinoma.
【24h】

Lymphatic micrometastases in patients with early esophageal adenocarcinoma.

机译:早期食道腺癌患者淋巴微转移。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Both endoscopic and surgical treatments are recommended for m3- or sm1-adenocarcinomas of the esophagus, depending on patients' lymph nodal status. Lymphatic dissemination is related to tumor infiltration depth, but varying incidences have been reported in m3- and sm1-adenocarcinomas. The study aim was to investigate whether the presence of occult tumor cells in lymph nodes could explain this variation. METHODS: Sixty-three node-negative (N0) patients with early esophageal adenocarcinoma (m2/m3/sm1-tumors) were included. Multilevel-sectioning of lymph nodes was performed; sections were stained by means of immunohistochemistry with cytokeratin marker CAM5.2. Two pathologists searched for micrometastases (0.2-2.0 mm) and isolated tumor cells (ITCs, <0.2 mm). RESULTS: Positive CAM5.2 staining in lymph nodes was not seen in any of the 18 m2-patients. In 2/25 m3-tumors (8.0%) an ITC was found, but no micrometastases. Tumor cells were identified in 4/20 sm1-tumors (20.0%): three micrometastases and one ITC. Median follow-up was 121 months. Two m3-patients (3.2%) died due to disease recurrence, including one patient in whom an ITC was detected. CONCLUSIONS: Lymphatic migration of tumor cells was found in node-negative m3- and sm1-adenocarcinomas of the esophagus (8.0% and 20.0%, respectively). However, the clinical relevance of these occult tumor cells should become apparent from large series of endoscopically treated patients.
机译:背景:根据患者的淋巴结地位,建议对食道的M3-或SM1腺癌的内窥镜和外科治疗。淋巴化散热与肿瘤浸润深度有关,但在M3和SM1腺癌中报告了不同的发病率。研究目的是调查淋巴结中隐匿性肿瘤细胞是否可以解释这种变化。方法:六十三节阴性(N0)患有早期食管腺癌(M2 / M3 / SM1-肿瘤)的患者。进行淋巴结的多级切片;通过用细胞角蛋白标记CAM5.2通过免疫组织化学染色部分。搜索微转移的两位病理学家(0.2-2.0 mm)和分离的肿瘤细胞(ITCs,<0.2mm)。结果:在18例M2患者中的任何一个中,淋巴结染色阳性CAM5.2染色。在2/25m 3-肿瘤中(8.0%)发现ITC,但没有微菌料。在4/20SM1-肿瘤中鉴定肿瘤细胞(20.0%):三微转移和一个ITC。中位后续时间为121个月。由于疾病复发,两种M3患者(3.2%)死亡,包括检测到ITC的一名患者。结论:在食道的节点阴性M3和SM1腺癌中发现肿瘤细胞的淋巴迁移(分别为8.0%和20.0%)。然而,这些隐匿性肿瘤细胞的临床相关性应从大系列内窥镜治疗的患者中变得显而易见。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号